INS and obesity due to melanocortin 4 receptor deficiency: Previously, Eckel and colleagues studied a relatively homogenous population with obesity and T2D and found that MCT improved insulin sensitivity in patients who already have metabolic dysfunction in a monitored inpatient setting [31].